Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Arcutis Biotherapeutics, Inc. Common Stock

ARQT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
ARQT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ARQT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ARQT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ARQT holdings by institutional investors

Quarterly net insider trading by ARQT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ARQT

7 former government officials from 6 congressional offices at 1 lobbying firm have lobbied for ARQT, most recently Sep 17, 2026.

  • Mike Kelly
    John Ray House New Legislative Assistant, Rep. Mike Kelly Formerly with Mike Kelly · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Sep 17, 2026
  • Cathy McMorris Rodgers
    Kristin Fritsch House New Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Senior Legislative Assistant, Office of Congresswoman Cathy McMorris Rodgers; Professional Staff Member House Committee on Energy and Commerce Formerly with Cathy McMorris Rodgers · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Sep 17, 2026
  • Tim Scott
    Cooper Chamblee Senate New Intern, Sen. Tim Scott Formerly with Tim Scott · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Sep 17, 2026
  • Lamar Alexander
    John Herzog Senate New Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President Formerly with Lamar Alexander · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Sep 17, 2026
  • Lamar Alexander
    Brett Meeks Senate New Deputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar Alexander Formerly with Lamar Alexander · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Sep 17, 2026
  • John Cornyn
    Laura Kemper Senate New Counsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human Services Formerly with John Cornyn · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Sep 17, 2026
  • Marsha Blackburn
    Keith Studdard House New Legislative Director, Rep. Marsha Blackburn Formerly with Marsha Blackburn · JEFFREY J. KIMBELL & ASSOCIATES, INC. · Sep 17, 2026

ARQT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ARQT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ARQT Income Statement
ARQT Balance Sheet
ARQT Cash Flow
U.S. Patents

New ARQT patent grants

  • Patent Title: Method for reducing side effects from administration of phosphodiesterase-4 inhibitors Aug. 04, 2026
  • Patent Title: Method for reducing side effects from administration of phosphodiesterase-4 inhibitors Jul. 21, 2026
  • Patent Title: Pharmaceutical compositions of spironolactone for deep dermal drug delivery Nov. 04, 2025
  • Patent Title: Topical roflumilast aerosol foams Oct. 28, 2025
  • Patent Title: Method for reducing side effects from administration of phosphodiesterase-4 inhibitors Aug. 19, 2025
  • Patent Title: Inhibition of crystal growth of roflumilast Jun. 24, 2025
  • Patent Title: Topical roflumilast formulation having antifungal properties Jun. 17, 2025
  • Patent Title: Topical roflumilast formulation having improved delivery and plasma half-life May. 27, 2025
  • Patent Title: Inhibition of crystal growth of roflumilast Mar. 25, 2025
  • Patent Title: Roflumilast formulations with an improved pharmacokinetic profile Feb. 11, 2025
  • Patent Title: Stable formulations of shr0302 Dec. 10, 2024
  • Patent Title: Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug Nov. 19, 2024
  • Patent Title: Laureth-4 containing topical formulations Sep. 10, 2024
  • Patent Title: Compositions and methods for deep dermal drug delivery Aug. 06, 2024
  • Patent Title: Method and formulation for improving roflumilast skin penetration lag time Jul. 23, 2024
  • Patent Title: Method for reducing side effects from administration of phosphodiesterase-4 inhibitors Jul. 23, 2024
  • Patent Title: Roflumilast formulations with an improved pharmacokinetic profile Jun. 25, 2024
  • Patent Title: Roflumilast formulations with an improved pharmacokinetic profile Jun. 18, 2024
  • Patent Title: Topical roflumilast formulation having improved delivery and plasma half-life Jun. 11, 2024
  • Patent Title: Topical roflumilast formulation having improved delivery and plasma half life Jun. 11, 2024
  • Patent Title: Method for reducing side effects from administration of phosphodiesterase-4 inhibitors May. 28, 2024
  • Patent Title: Topical roflumilast formulation having improved delivery and plasma half-life Nov. 21, 2023
  • Patent Title: Inhibition of crystal growth of roflumilast Oct. 24, 2023
  • Patent Title: Laureth-4 containing topical formulations Aug. 22, 2023
  • Patent Title: Topical roflumilast formulation having antifungal properties Jul. 25, 2023
  • Patent Title: Compositions and methods for deep dermal drug delivery Apr. 18, 2023
  • Patent Title: Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents Dec. 27, 2022
  • Patent Title: Topical roflumilast formulation having improved delivery and plasma half life Sep. 28, 2021
Government Contracts

Estimated quarterly amount awarded to ARQT from public contracts

ARQT News

Recent insights relating to ARQT

CNBC Recommendations

Recent picks made for ARQT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ARQT

ARQT Analyst Ratings

ARQT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ARQT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ARQT stock a Buy, Sell, or Hold?

  • What is the price target for $ARQT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ARQT Top Shareholders
Shareholder
Shares Held
ARQT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ARQT stock?

  • Who owns the most shares of $ARQT stock?

  • What funds own $ARQT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ARQT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ARQT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ARQT

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

  • Address Westlake Village, CA
  • Market Cap 3.3 billion
  • Employees 354
  • Industrial Classification Pharmaceutical Preparations

Arcutis Biotherapeutics, Inc. Common Stock (ARQT) Historical Stock Prices

Arcutis Biotherapeutics, Inc. Common Stock (ARQT) closed at $26.27 on September 24, 2026. Over the past year its adjusted close ranged from $16.73 to $31.20. Daily prices go back to January 31, 2020, 1,671 trading days in all.

  • 1 month+5.67%
  • 3 months-1.57%
  • Year to date-9.54%
  • 1 year+51.85%
  • 3 years+354.50%
  • 5 years+13.33%
  • Max+20.50%
See every congressional and insider trade on the ARQT price chart

Quiver Premium charts ARQT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 26.22 26.68 25.19 26.27 26.27 2,177,536
Sep 23, 2026 27.79 28.02 26.07 26.38 26.38 2,512,212
Sep 22, 2026 25.90 28.29 25.69 27.78 27.78 2,857,941
Sep 21, 2026 25.57 26.08 25.19 25.96 25.96 1,888,258
Sep 18, 2026 26.14 26.75 25.13 25.38 25.38 19,137,072
Sep 17, 2026 25.95 26.62 24.34 26.46 26.46 5,862,795
Sep 16, 2026 23.63 26.39 23.63 26.14 26.14 5,156,098
Sep 15, 2026 24.23 24.28 23.10 23.51 23.51 3,459,265
Sep 14, 2026 23.79 24.75 23.79 24.27 24.27 2,031,572
Sep 11, 2026 23.63 24.18 23.55 23.89 23.89 2,044,715
Sep 10, 2026 23.70 23.84 23.25 23.38 23.38 1,785,461
Sep 9, 2026 24.05 24.46 23.74 23.84 23.84 2,314,509
Sep 8, 2026 24.84 25.13 24.09 24.39 24.39 4,560,362
Sep 4, 2026 23.27 24.02 23.27 23.90 23.90 1,631,999
Sep 3, 2026 24.13 24.13 23.47 23.66 23.66 1,122,316
Sep 2, 2026 23.95 24.45 23.40 23.85 23.85 1,950,718
Sep 1, 2026 23.79 24.11 23.54 23.75 23.75 1,101,734
Aug 31, 2026 23.75 24.07 23.21 23.97 23.97 1,522,731
Aug 28, 2026 24.60 24.88 23.74 23.78 23.78 1,536,018
Aug 27, 2026 24.95 25.15 24.60 24.87 24.87 2,204,696
Aug 26, 2026 24.85 25.50 24.45 25.14 25.14 1,911,324
Aug 25, 2026 25.01 25.34 24.75 24.86 24.86 1,185,616
Aug 24, 2026 24.80 25.21 24.49 24.78 24.78 1,128,432
Aug 21, 2026 25.49 25.67 24.73 25.08 25.08 2,159,329
Aug 20, 2026 26.50 26.56 24.53 25.35 25.35 3,289,276
Aug 19, 2026 27.00 27.19 26.37 26.46 26.46 1,025,411
Aug 18, 2026 25.51 26.71 25.49 26.54 26.54 1,972,077
Aug 17, 2026 26.20 26.34 25.51 25.61 25.61 1,710,163
Aug 14, 2026 25.39 26.23 25.28 26.19 26.19 1,109,513
Aug 13, 2026 26.57 26.65 25.77 25.83 25.83 1,585,686
Aug 12, 2026 26.62 26.62 25.92 26.28 26.28 1,184,073
Aug 11, 2026 26.24 26.82 25.82 26.23 26.23 1,050,003
Aug 10, 2026 24.93 25.95 24.76 25.92 25.92 2,094,918
Aug 7, 2026 26.65 26.88 25.27 25.29 25.29 2,449,133
Aug 6, 2026 29.21 29.24 26.23 26.43 26.43 3,264,375
Aug 5, 2026 26.07 27.11 26.06 27.10 27.10 2,448,788
Aug 4, 2026 26.07 26.41 25.84 26.03 26.03 1,939,087
Aug 3, 2026 26.67 26.86 25.63 25.94 25.94 1,570,530
Jul 31, 2026 27.77 27.96 26.32 26.86 26.86 1,548,716
Jul 30, 2026 28.01 28.14 27.33 27.99 27.99 1,266,701
Jul 29, 2026 28.18 28.52 27.72 27.86 27.86 977,252
Jul 28, 2026 28.09 28.53 27.51 28.42 28.42 1,066,059
Jul 27, 2026 27.62 28.60 27.54 27.84 27.84 1,199,084
Jul 24, 2026 27.50 27.69 26.78 27.35 27.35 819,355
Jul 23, 2026 27.30 27.93 26.98 27.33 27.33 1,031,412
Jul 22, 2026 28.05 28.46 27.69 27.90 27.90 802,453
Jul 21, 2026 27.53 28.50 27.52 28.26 28.26 1,370,446
Jul 20, 2026 28.54 28.98 27.50 27.53 27.53 1,254,200
Jul 17, 2026 27.49 28.87 27.43 28.49 28.49 1,265,376
Jul 16, 2026 27.79 28.05 27.32 27.74 27.74 1,749,961
Jul 15, 2026 26.91 27.98 26.50 27.78 27.78 1,508,330
Jul 14, 2026 27.28 27.28 26.49 26.81 26.81 771,512
Jul 13, 2026 27.25 27.45 26.01 27.12 27.12 1,439,118
Jul 10, 2026 28.66 28.98 26.96 27.74 27.74 1,572,249
Jul 9, 2026 28.40 29.84 28.26 28.78 28.78 1,738,482
Jul 8, 2026 27.37 28.55 27.28 28.50 28.50 1,804,101
Jul 7, 2026 26.30 27.80 26.10 27.67 27.67 2,397,370
Jul 6, 2026 25.84 26.17 25.25 26.07 26.07 1,290,402
Jul 2, 2026 25.86 26.11 25.53 25.81 25.81 1,198,181
Jul 1, 2026 26.40 26.46 25.83 25.84 25.84 937,771
Jun 30, 2026 27.15 27.20 25.83 26.22 26.22 1,354,101
Jun 29, 2026 26.77 27.18 26.12 26.76 26.76 1,386,238
Jun 26, 2026 26.79 27.25 26.44 27.00 27.00 3,711,679
Jun 25, 2026 27.41 28.38 26.63 26.69 26.69 1,971,901
Jun 24, 2026 26.46 28.14 26.46 27.37 27.37 2,069,683
Jun 23, 2026 26.56 27.17 26.18 26.27 26.27 1,664,015
Jun 22, 2026 26.42 27.17 26.24 26.66 26.66 1,528,828
Jun 18, 2026 26.69 27.00 25.43 26.21 26.21 5,480,646
Jun 17, 2026 25.67 26.66 25.66 26.22 26.22 1,625,101
Jun 16, 2026 25.67 25.83 25.09 25.67 25.67 1,537,144
Jun 15, 2026 24.62 25.62 24.04 25.58 25.58 1,792,609
Jun 12, 2026 24.64 24.99 24.25 24.38 24.38 1,329,450
Jun 11, 2026 23.20 25.34 22.95 24.59 24.59 2,748,967
Jun 10, 2026 22.65 24.00 22.56 23.23 23.23 1,412,384
Jun 9, 2026 21.90 22.87 21.72 22.79 22.79 1,777,447
Jun 8, 2026 21.45 21.57 21.00 21.54 21.54 1,120,840
Jun 5, 2026 21.85 22.19 21.03 21.23 21.23 1,209,414
Jun 4, 2026 21.44 22.07 21.27 21.95 21.95 1,173,406
Jun 3, 2026 20.79 21.52 20.65 21.35 21.35 1,062,795
Jun 2, 2026 21.05 21.10 20.48 20.79 20.79 2,311,607
Jun 1, 2026 21.36 21.52 20.91 21.47 21.47 1,602,388
May 29, 2026 21.45 21.59 21.09 21.46 21.46 1,629,709
May 28, 2026 21.15 21.89 21.13 21.44 21.44 956,977
May 27, 2026 21.33 22.06 21.11 21.15 21.15 1,504,254
May 26, 2026 20.97 21.34 20.73 21.11 21.11 2,609,901
May 22, 2026 21.01 21.41 20.63 20.86 20.86 1,163,046
May 21, 2026 20.16 21.13 20.14 21.01 21.01 1,428,047
May 20, 2026 19.65 20.76 19.65 20.47 20.47 2,325,925
May 19, 2026 20.02 20.08 19.30 19.50 19.50 4,512,182
May 18, 2026 21.30 21.34 19.96 20.03 20.03 1,412,121
May 15, 2026 21.13 21.84 21.00 21.32 21.32 1,600,525
May 14, 2026 21.75 22.45 21.46 21.57 21.57 1,865,777
May 13, 2026 20.17 22.06 19.93 21.69 21.69 3,663,265
May 12, 2026 21.30 21.56 20.27 20.69 20.69 2,313,855
May 11, 2026 21.32 21.72 20.94 21.24 21.24 3,327,291
May 8, 2026 20.71 21.36 20.25 21.17 21.17 2,715,306
May 7, 2026 22.82 23.77 20.19 20.66 20.66 6,774,510
May 6, 2026 23.81 24.27 23.25 24.17 24.17 1,383,544
May 5, 2026 23.72 24.03 23.15 23.42 23.42 850,256
May 4, 2026 23.15 23.95 23.13 23.49 23.49 1,277,761
May 1, 2026 23.22 23.77 22.75 23.35 23.35 1,021,039
Apr 30, 2026 22.58 23.34 22.47 23.22 23.22 1,418,645
Apr 29, 2026 22.86 23.14 22.13 22.37 22.37 1,120,594
Apr 28, 2026 23.66 24.00 22.93 23.29 23.29 995,694
Apr 27, 2026 23.32 24.15 23.15 23.42 23.42 823,548
Apr 24, 2026 22.62 23.30 22.53 23.26 23.26 1,090,581
Apr 23, 2026 23.75 23.87 22.45 22.86 22.86 1,061,020
Apr 22, 2026 23.60 23.91 23.44 23.75 23.75 826,189
Apr 21, 2026 24.27 24.27 23.26 23.40 23.40 989,821
Apr 20, 2026 24.43 24.50 23.88 24.47 24.47 887,355
Apr 17, 2026 24.76 24.80 24.23 24.53 24.53 1,158,642
Apr 16, 2026 24.56 24.62 23.68 24.19 24.19 900,782
Apr 15, 2026 25.09 25.33 24.21 24.58 24.58 775,532
Apr 14, 2026 24.30 25.47 24.22 25.09 25.09 1,611,764
Apr 13, 2026 23.87 24.51 23.82 24.12 24.12 812,871
Apr 10, 2026 24.47 24.54 23.59 24.21 24.21 894,690
Apr 9, 2026 24.26 25.03 24.03 24.57 24.57 837,936
Apr 8, 2026 24.28 24.70 23.65 24.61 24.61 1,169,999
Apr 7, 2026 23.47 23.52 22.96 23.27 23.27 775,246
Apr 6, 2026 23.67 24.24 23.44 23.66 23.66 1,391,213
Apr 2, 2026 23.40 24.08 23.20 23.63 23.63 1,092,242
Apr 1, 2026 23.85 24.52 23.65 24.10 24.10 1,351,230
Mar 31, 2026 21.90 23.68 21.84 23.56 23.56 2,062,646
Mar 30, 2026 21.50 21.59 21.12 21.33 21.33 1,313,835
Mar 27, 2026 22.23 22.53 21.13 21.22 21.22 1,357,106
Mar 26, 2026 22.52 22.89 22.35 22.38 22.38 611,302
Mar 25, 2026 22.03 23.00 21.95 22.74 22.74 821,159
Mar 24, 2026 22.09 22.25 21.57 21.83 21.83 1,199,846
Mar 23, 2026 22.92 23.46 22.12 22.29 22.29 1,034,263
Mar 20, 2026 22.76 23.29 22.13 22.21 22.21 4,095,423
Mar 19, 2026 22.00 23.00 21.86 22.91 22.91 1,283,076
Mar 18, 2026 22.45 22.84 22.20 22.24 22.24 1,984,954
Mar 17, 2026 22.76 22.97 22.31 22.72 22.72 1,402,531
Mar 16, 2026 23.12 23.20 22.56 22.76 22.76 1,135,863
Mar 13, 2026 23.09 23.45 22.61 22.75 22.75 890,479
Mar 12, 2026 23.44 23.44 22.50 22.91 22.91 1,087,070
Mar 11, 2026 24.36 24.50 23.51 23.95 23.95 630,854
Mar 10, 2026 25.12 25.53 24.39 24.59 24.59 1,309,453
Mar 9, 2026 23.92 24.93 23.76 24.82 24.82 1,035,960
Mar 6, 2026 23.57 24.09 23.25 24.00 24.00 1,113,169
Mar 5, 2026 23.70 24.30 23.69 23.97 23.97 1,241,428
Mar 4, 2026 23.45 24.56 22.85 24.12 24.12 1,421,238
Mar 3, 2026 24.04 24.53 22.89 23.60 23.60 1,889,399
Mar 2, 2026 25.93 26.12 24.65 24.76 24.76 2,045,130
Feb 27, 2026 27.95 28.15 26.60 26.97 26.97 2,129,839
Feb 26, 2026 27.69 28.80 24.87 28.57 28.57 3,378,540
Feb 25, 2026 27.04 27.65 26.76 27.01 27.01 1,399,767
Feb 24, 2026 26.08 27.02 26.08 26.98 26.98 786,666
Feb 23, 2026 25.50 26.45 24.88 26.31 26.31 1,156,003
Feb 20, 2026 27.74 28.12 24.95 25.41 25.41 2,716,557
Feb 19, 2026 26.59 28.01 26.28 27.95 27.95 1,213,237
Feb 18, 2026 26.60 27.32 26.53 26.71 26.71 1,132,756
Feb 17, 2026 25.85 26.66 25.50 26.61 26.61 1,177,917
Feb 13, 2026 26.85 26.97 25.83 25.86 25.86 786,462
Feb 12, 2026 26.68 26.76 25.89 26.71 26.71 1,099,967
Feb 11, 2026 26.91 27.18 25.84 26.59 26.59 675,278
Feb 10, 2026 26.74 27.24 26.47 26.88 26.88 696,589
Feb 9, 2026 27.33 27.62 26.60 26.88 26.88 883,734
Feb 6, 2026 26.50 27.50 26.41 27.32 27.32 1,363,028
Feb 5, 2026 26.18 26.73 25.96 26.07 26.07 1,539,089
Feb 4, 2026 26.06 26.20 25.58 26.08 26.08 2,300,331
Feb 3, 2026 25.43 26.67 25.03 26.19 26.19 979,851
Feb 2, 2026 25.03 25.75 24.50 25.57 25.57 1,443,458
Jan 30, 2026 25.37 25.63 24.96 25.37 25.37 929,206
Jan 29, 2026 25.29 25.95 25.22 25.73 25.73 1,250,396
Jan 28, 2026 26.19 26.39 25.39 25.45 25.45 742,791
Jan 27, 2026 26.32 26.97 26.01 26.33 26.33 745,518
Jan 26, 2026 25.80 26.62 25.51 26.32 26.32 1,129,154
Jan 23, 2026 26.41 26.90 26.09 26.20 26.20 1,317,252
Jan 22, 2026 26.69 27.08 26.18 26.65 26.65 1,699,242
Jan 21, 2026 25.74 26.75 25.57 26.70 26.70 1,741,768
Jan 20, 2026 25.32 26.00 25.12 25.87 25.87 995,450
Jan 16, 2026 26.49 26.62 25.80 25.85 25.85 1,110,987
Jan 15, 2026 26.65 26.89 25.99 26.36 26.36 1,105,062
Jan 14, 2026 25.85 26.93 25.77 26.73 26.73 1,289,011
Jan 13, 2026 26.69 26.78 25.35 26.05 26.05 2,025,597
Jan 12, 2026 27.75 28.10 25.45 26.78 26.78 4,007,642
Jan 9, 2026 30.00 30.75 28.11 28.22 28.22 1,745,882
Jan 8, 2026 29.18 30.26 28.86 29.88 29.88 1,695,994
Jan 7, 2026 29.37 30.60 28.75 29.58 29.58 1,564,497
Jan 6, 2026 30.01 30.44 29.12 29.22 29.22 1,387,659
Jan 5, 2026 29.03 30.24 28.60 30.20 30.20 1,842,178
Jan 2, 2026 28.94 29.88 28.49 29.00 29.00 1,652,788
Dec 31, 2025 28.08 29.66 28.08 29.04 29.04 1,873,818
Dec 30, 2025 28.47 28.65 27.71 28.08 28.08 1,393,297
Dec 29, 2025 28.99 29.09 28.30 28.56 28.56 1,996,334
Dec 26, 2025 29.31 29.39 28.84 28.97 28.97 1,312,856
Dec 24, 2025 29.34 29.55 29.14 29.45 29.45 383,210
Dec 23, 2025 29.75 30.26 29.28 29.31 29.31 1,404,702
Dec 22, 2025 28.26 30.00 27.97 29.90 29.90 2,181,863
Dec 19, 2025 28.00 28.66 27.82 28.01 28.01 3,981,881
Dec 18, 2025 28.54 28.90 27.55 27.78 27.78 1,926,342
Dec 17, 2025 28.58 28.69 28.05 28.34 28.34 1,424,920
Dec 16, 2025 28.64 29.43 28.37 28.53 28.53 3,286,054
Dec 15, 2025 29.20 29.50 28.45 28.95 28.95 2,300,079
Dec 12, 2025 29.35 29.50 28.30 29.02 29.02 2,218,544
Dec 11, 2025 29.81 30.14 29.32 29.47 29.47 2,412,392
Dec 10, 2025 29.92 30.20 29.30 29.77 29.77 1,292,962
Dec 9, 2025 30.85 31.12 29.33 29.76 29.76 2,144,858
Dec 8, 2025 31.40 31.77 30.88 31.03 31.03 2,585,871
Dec 5, 2025 31.03 31.45 30.39 31.20 31.20 1,284,747
Dec 4, 2025 29.37 31.39 29.37 31.16 31.16 2,041,264
Dec 3, 2025 29.76 30.18 29.28 29.96 29.96 1,838,566
Dec 2, 2025 30.14 30.48 28.95 29.43 29.43 2,033,035
Dec 1, 2025 30.24 30.65 29.85 30.37 30.37 1,576,797
Nov 28, 2025 31.27 31.27 30.39 30.65 30.65 1,090,812
Nov 26, 2025 30.98 31.11 30.38 30.96 30.96 1,925,096
Nov 25, 2025 30.75 31.00 30.25 30.73 30.73 1,707,759
Nov 24, 2025 29.84 31.09 29.64 30.76 30.76 3,801,635
Nov 21, 2025 27.15 30.01 27.08 29.49 29.49 2,594,317
Nov 20, 2025 28.40 28.49 27.22 27.33 27.33 2,876,139
Nov 19, 2025 27.21 28.96 27.00 27.89 27.89 3,459,284
Nov 18, 2025 25.87 27.92 25.55 27.28 27.28 3,248,090
Nov 17, 2025 24.86 26.82 24.82 26.17 26.17 4,606,960
Nov 14, 2025 22.28 25.20 22.26 25.00 25.00 3,954,003
Nov 13, 2025 23.37 23.77 22.78 22.86 22.86 2,421,823
Nov 12, 2025 24.05 24.39 23.24 23.45 23.45 1,589,867
Nov 11, 2025 23.62 24.12 23.39 24.03 24.03 1,632,545
Nov 10, 2025 24.70 24.86 23.74 23.75 23.75 2,514,050
Nov 7, 2025 25.11 25.12 23.32 24.23 24.23 3,019,522
Nov 6, 2025 23.93 25.35 23.77 25.10 25.10 2,636,722
Nov 5, 2025 23.79 24.55 23.52 24.38 24.38 2,683,580
Nov 4, 2025 23.95 24.59 23.85 24.01 24.01 2,899,223
Nov 3, 2025 25.15 25.43 24.22 24.76 24.76 2,093,384
Oct 31, 2025 24.69 25.56 24.63 25.31 25.31 2,300,159
Oct 30, 2025 25.89 27.08 24.77 24.92 24.92 3,060,990
Oct 29, 2025 25.84 25.99 23.48 25.29 25.29 5,449,157
Oct 28, 2025 22.50 25.75 22.00 24.95 24.95 12,063,173
Oct 27, 2025 20.33 20.60 19.60 19.64 19.64 1,826,475
Oct 24, 2025 20.32 20.32 19.95 20.11 20.11 1,186,550
Oct 23, 2025 19.80 20.36 19.68 20.08 20.08 1,188,874
Oct 22, 2025 20.44 20.73 19.66 19.81 19.81 1,517,480
Oct 21, 2025 20.89 20.94 20.55 20.64 20.64 869,614
Oct 20, 2025 21.20 21.20 20.42 20.88 20.88 1,690,476
Oct 17, 2025 20.63 21.09 20.30 20.88 20.88 1,320,869
Oct 16, 2025 21.75 21.84 20.34 20.91 20.91 1,618,702
Oct 15, 2025 20.50 21.71 20.46 21.63 21.63 1,977,891
Oct 14, 2025 20.49 20.61 20.16 20.43 20.43 1,037,991
Oct 13, 2025 20.21 21.06 20.16 20.72 20.72 2,022,372
Oct 10, 2025 20.73 20.73 19.76 20.05 20.05 1,824,602
Oct 9, 2025 21.14 21.41 20.57 20.71 20.71 1,632,505
Oct 8, 2025 20.63 21.56 20.40 21.24 21.24 2,521,702
Oct 7, 2025 19.84 20.89 19.41 20.57 20.57 1,926,970
Oct 6, 2025 19.89 20.45 19.65 19.76 19.76 2,145,893
Oct 3, 2025 21.30 21.30 19.85 19.92 19.92 2,661,340
Oct 2, 2025 20.00 21.29 19.52 21.25 21.25 2,789,290
Oct 1, 2025 18.90 20.10 18.79 19.76 19.76 3,343,409
Sep 30, 2025 18.87 19.36 18.62 18.85 18.85 2,558,038
Sep 29, 2025 17.73 19.21 17.67 18.62 18.62 4,251,865
Sep 26, 2025 16.75 17.70 16.71 17.57 17.57 1,435,203
Sep 25, 2025 17.20 17.35 16.57 16.73 16.73 1,024,830
Sep 24, 2025 17.64 17.95 17.15 17.30 17.30 979,741

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Arcutis Biotherapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ARQT, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation